Several studies have indicated that GPC3-targeted CAR-T cells that overexpress GLUT1 or AGK demonstrate improved CD8 T-cell persistence in vivo and greater antitumor effects in HCC (34). This evidence concerns the gene GPC3 and hepatocellular carcinoma.